EyePoint (EYPT) Total Non-Current Liabilities (2011 - 2026)

EyePoint (EYPT) reported Total Non-Current Liabilities of $57.7 million for Q1 2026, down 9.85% on a YoY basis from $64.0 million in Q1 2025, and little changed sequentially from $57.8 million in Q4 2025.

EyePoint (EYPT) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

EyePoint (EYPT) has 11 years of Total Non-Current Liabilities data on file, last reported at $57.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities fell 9.85% year-over-year to $57.7 million; the trailing twelve-month figure through Mar 2026 stood at $57.7 million (down 9.85% YoY), and the FY2025 full-year result was $57.8 million, down 29.31% from the prior year.
  • Total Non-Current Liabilities held at $57.7 million in Q1 2026, from $57.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $118.4 million in Q2 2023 to a low of $51.4 million in Q3 2025.
  • A 5-year average of $78.5 million and a median of $81.5 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities soared 45.33% in 2023 and sank 42.69% in 2025, its largest moves.
  • Tracing EYPT's Total Non-Current Liabilities over 5 years: stood at $83.4 million in 2022, then advanced by 6.56% to $88.9 million in 2023, then decreased by 7.99% to $81.8 million in 2024, then fell by 29.31% to $57.8 million in 2025, then slipped by 0.18% to $57.7 million in 2026.
  • Business Quant data shows EYPT's Total Non-Current Liabilities at $57.7 million in Q1 2026, $57.8 million in Q4 2025, and $51.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 57.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.69 Mn
Dec 31, 2025 57.80 Mn
Sep 30, 2025 51.40 Mn
Jun 30, 2025 54.99 Mn
Mar 31, 2025 63.99 Mn
Dec 31, 2024 81.76 Mn
Sep 30, 2024 81.95 Mn
Jun 30, 2024 95.94 Mn
Mar 31, 2024 79.21 Mn
Dec 31, 2023 88.86 Mn
Sep 30, 2023 101.42 Mn
Jun 30, 2023 118.39 Mn
Mar 31, 2023 75.60 Mn
Dec 31, 2022 83.39 Mn
Sep 30, 2022 83.54 Mn
Jun 30, 2022 81.47 Mn
Mar 31, 2022 77.08 Mn
Dec 31, 2021 76.64 Mn
Sep 30, 2021 73.14 Mn
Jun 30, 2021 69.63 Mn